About
Graham Mills joined Abingworth's London office in January 2022, working with the transatlantic team to evaluate new investment opportunities and support existing portfolio companies with a therapeutic area-agnostic focus. He previously worked with JJDC, the corporate investment arm of Johnson & Johnson, and with pan-European VC Seroba Life Sciences, and was Founder and Managing Director of healthcare technology startup Techspert. He holds a PhD in Medical Biology from the University of Cambridge and a BA in Genetics from Trinity College Dublin.
Invests in
Biotech
Colleagues at Abingworth
Alex Asquith
Counsel at Abingworth
Andrew Sinclair
Managing Director, Head of Publics & Late Stage at Abingworth
Ankur Shah
Vice President, CCD at Abingworth
Anna Slezak
Senior Associate at Abingworth
Bali Muralidhar
Global Head of Life Sciences & CIO at Abingworth
Carlos Paya
Venture Partner at Abingworth
Dayle Hogg
Operating Executive at Abingworth
Diya Malhotra
Principal at Abingworth
Frequently asked questions
- Who is Graham Mills?
- Graham Mills joined Abingworth's London office in January 2022, working with the transatlantic team to evaluate new investment opportunities and support existing portfolio companies with a therapeutic area-agnostic focus. He previously worked with JJDC, the corporate investment arm of Johnson & Johnson, and with pan-European VC Seroba Life Sciences, and was Founder and Managing Director of healthcare technology startup Techspert. He holds a PhD in Medical Biology from the University of Cambridge and a BA in Genetics from Trinity College Dublin.
- Where does Graham Mills work?
- Graham Mills is Principal at Abingworth.
- What does Graham Mills invest in?
- Graham Mills invests in Biotech.